Bluejay Diagnostics, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Bluejay Diagnostics, Inc. (BJDX) reported Net Income (Loss) Available to Common Stockholders, Basic of -$6.85 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-03-06
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$1.43M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$1.60M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was -$1.43M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was -$14.71M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$6.85M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$20.94M.
- Bluejay Diagnostics, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$9.95M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$3.03M derived: sum of 2 quarters · filed 2026-03-06 | -$6.85M 10-K · filed 2026-03-06 | |
| 2025-09-30 | -$1.60M 10-Q · filed 2025-11-07 | -$5.42M 10-Q · filed 2025-11-07 | ||
| 2024-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$16.14M derived: sum of 2 quarters · filed 2026-03-06 | -$20.94M 10-K · filed 2026-03-06 | |
| 2024-09-30 | -$14.71M 10-Q · filed 2025-11-07 | -$19.51M 10-Q · filed 2025-11-07 | ||
| 2023-12-31 | -$9.95M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |